Cited by 89Fatty Acid Research and HealthNutritional Studies and DietLipoproteins and Cardiovascular Health

Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease in US Men and Women

Open access
Malik, Vasanti S., Chiuve, Stephanie E., Campos, Hannia, Rimm, Eric B., Mozaffarian, Dariush, Hu, Frank B., Sun, Qi·2015·Circulation

Abstract

Background—: Circulating very-long-chain saturated fatty acids (VLCSFAs) may play an active role in the origin of cardiometabolic diseases. Methods and Results—: We measured 3 VLCSFAs (C20:0, C22:0, and C24:0) in plasma and erythrocytes using gas-liquid chromatography among 794 incident coronary heart disease (CHD) cases who were prospectively identified and confirmed among women in the Nurses’ Health Study (NHS; 1990–2006) and among men in the Health Professionals Follow-Up Study (HPFS; 1994–2008). A total of 1233 CHD-free controls were randomly selected and matched to cases in these 2 cohorts. Conditional logistic regression was used to estimate hazard ratios and 95% confidence intervals. Plasma VLCSFAs were correlated with favorable profiles of blood lipids, C-reactive protein, and adiponectin in the NHS and HPFS and with fasting insulin and C-peptide levels in a nationally representative US comparison population. After multivariate adjustment for lifestyle factors, body mass index, diet, and long-chain n-3 and trans fatty acids, total VLCSFAs in plasma were associated with a 52% decreased risk of CHD (pooled hazard ratio, 0.48; 95% confidence interval, 0.32–0.72, comparing extreme quintiles; P trend <0.0001). For VLCSFAs in erythrocytes, a nonsignificant inverse trend with CHD risk was observed (pooled hazard ratio, 0.66; 95% confidence interval, 0.41–1.06, comparing extreme quintiles; P trend =0.16). Conclusions—: In US men and women, plasma VLCSFAs were independently associated with favorable profiles of blood lipids and other cardiovascular disease risk markers and a lower risk of CHD. Erythrocyte VLCSFAs were associated with nonsignificant trends of lower CHD risk. Future studies are warranted to elucidate the underlying biological mechanisms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.114.014911

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Palmitic acid (16:0) exhibits in vitro adverse effects; whereas medium-chain (6:0-12:0), odd-chain (15:0, 17:0), and very long-chain (20:0-24:0) saturated fats may have metabolic benefits.

    “For instance, palmitic acid (16:0) exhibits in vitro adverse effects; whereas medium-chain (6:0-12:0), odd-chain (15:0, 17:0), and very long-chain (20:0-24:0) saturated fats may have metabolic benefits.61, 338, 339”
  • Saturated fat represents a highly heterogeneous category, with fatty acid chain lengths ranging from 6 to 24 carbons, deriving from diverse foods, and possessing dissimilar biology.

    “Saturated fat represents a highly heterogeneous category, with fatty acid chain lengths ranging from 6 to 24 carbons, deriving from diverse foods, and possessing dissimilar biology.”
  • Palmitic acid (16:0) exhibits in vitro adverse effects; whereas medium-chain (6:0-12:0), odd-chain (15:0, 17:0), and very long-chain (20:0-24:0) saturated fats may have metabolic benefits.

    “For instance, palmitic acid (16:0) exhibits in vitro adverse effects; whereas medium-chain (6:0-12:0), odd-chain (15:0, 17:0), and very long-chain (20:0-24:0) saturated fats may have metabolic benefits.61, 338, 339”
  • Saturated fat represents a highly heterogeneous category, with fatty acid chain lengths ranging from 6 to 24 carbons, deriving from diverse foods, and possessing dissimilar biology.

    “Saturated fat represents a highly heterogeneous category, with fatty acid chain lengths ranging from 6 to 24 carbons, deriving from diverse foods, and possessing dissimilar biology.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Malik, V. S., Chiuve, S. E., Campos, H., Rimm, E. B., Mozaffarian, D., Hu, F. B., & Sun, Q.
Affiliations
Tufts University (US)
Venue
Circulation
Published
2015-07-28
Volume
132
Issue
4
Pages
260-268
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1908513419
Cited by
89
References
31
Citations by year
2026: 3 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 8 · 2021: 19 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 3 · 2016: 6
FWCI
6.10
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (1r01es014433-01a2, 5r01ca049449-18)
  • National Heart, Lung, and Blood Institute (HL60712, R01HL060712, R01HL035464, R00HL097068, HL35464, R00HL098459, HL-088521, HL34594, R01HL034594, R01HL088521)
  • National Cancer Institute (CA-167552, CA-49449, CA-87969, P01CA087969, CA-186107, R01‐CA049449, UM1CA186107, U01CA049449, UM1CA167552, U01CA167552)
  • National Institute of Environmental Health Sciences (R01-ES014433)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
very long-chain saturated fatty acids, coronary artery disease, plasma fatty acids, erythrocyte fatty acids, serum lipids, C-reactive protein, adiponectin, insulin, C-peptide, cardiovascular risk markers, Nurses' Health Study, Health Professionals Follow-up Study
MeSH terms
Adult, Aged, C-Reactive Protein, Coronary Disease, Fatty Acids, Female, Follow-Up Studies, Humans, Lipids, Male, Middle Aged, Prospective Studies, Retrospective Studies, United States, Cohort Studies, Biomarkers, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review